HCA Healthcare dividend and valuation
Valuation
HCA Healthcare paid $3.06 per share in dividends over the last 12 months (yield 0.6%). Next ex-dividend date: December 15, 2026. The P/E ratio is 17.0. The average price target of 22 analysts is $483.41.
What would HCA Healthcare's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 17, 2026
HCA Healthcare compared with similar companies
HCA Healthcare's P/E (trailing 12 months): 17.0, in line with the median of a group of 11 similar companies (17.2).
| Metric | HCA Healthcare | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 17.0 | 17.2 | 14.9 – 29.3 | Middle |
| Forward P/E | 16.3 | 16.3 | 13.4 – 22.8 | Middle |
| EV/EBITDA | 10.2 | 11.5 | 8.18 – 16.6 | Middle |
| Price/sales | 1.36 | 1.36 | 1.09 – 2.78 | Middle |
| Gross margin | 42.8% | 35.5% | 27.4% – 43.5% | Middle |
| Operating margin | 15.3% | 15.3% | 11.5% – 18.9% | Middle |
| Net margin | 8.6% | 8.1% | 7.4% – 10.3% | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
HCA Healthcare: valuation over time
On the latest fiscal year's earnings (2025), HCA Healthcare's P/E today is 17.7, above the median of its last 10 fiscal years (14.0; between 10.1 and 16.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (0.6%) is below the median of the last 8 fiscal years (0.9%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | $466.86 | $28.33 | 16.5 | $2.88 | 0.6% |
| 2024 | $300.15 | $22.00 | 13.6 | $2.64 | 0.9% |
| 2023 | $270.68 | $18.97 | 14.3 | $2.40 | 0.9% |
| 2022 | $239.96 | $19.15 | 12.5 | $2.24 | 0.9% |
| 2021 | $256.92 | $21.16 | 12.1 | $1.92 | 0.7% |
| 2020 | $164.46 | $10.93 | 15.0 | $0.43 | 0.3% |
| 2019 | $147.81 | $10.07 | 14.7 | $1.60 | 1.1% |
| 2018 | $124.45 | $10.66 | 11.7 | $1.40 | 1.1% |
| 2017 | $87.84 | $5.95 | 14.8 | — | — |
| 2016 | $74.02 | $7.30 | 10.1 | — | — |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $106.91B
- Enterprise value
- $161.79B
- PEG
- 1.53
- EV/revenue
- 2.06
Profitability and growth
- ROA
- 12.2%
- ROIC
- 21.4%
- Revenue growth (year over year)
- 3.6%
- Earnings growth (year over year)
- 4.5%
Financial health
- Total cash
- $1.02B
- Total debt
- $52.43B
- Current ratio
- 0.82
- Quick ratio
- 0.63
- Altman Z-Score
- 2.52
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- $3.06
- Dividend yield
- 0.6%
- Payout ratio
- 10.1%
- Ex-dividend date
- December 15, 2026
Analysts and estimates
- Average price target
- $483.41
- Median price target
- $488.00
- High price target
- $585.00
- Low price target
- $380.00
- Analysts with a price target
- 22
- Consensus
- Buy
- Forward EPS
- $31.30
- EPS estimate, current year
- $30.05
Shares and trading
- Beta
- 1.10
- Average volume
- 1.36M
- Shares outstanding
- 208.89M
- Float
- 136.72M
- Institutional ownership
- 78.3%
- Insider ownership
- 17.2%
- Short interest (% of float)
- 3.6%
- Short ratio (days)
- 3.82
